Treatment With Hepcludex® Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks Pharmaceutical Investing
MAVIRET® Approved by Health Canada for Paediatric Patients with Chronic Hepatitis C Pharmaceutical Investing
Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin Biotech Investing
Sirona Biochem Contracts WuXi AppTec to Manufacture Revolutionary Anti-Aging/Anti-Wrinkle Compound for Clinical Trial Company News
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress 2022 Pharmaceutical Investing
The Gummy Project Announces eShipper as Warehousing, Shipping and Fulfillment Partner in Preparation for Official Launch of Gummy Products Biotech Investing
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant ) to Support Label Expansion for the Preventive Treatment of Migraine Pharmaceutical Investing
AMGEN FOUNDATION MORE THAN DOUBLES COMMITMENT TO LABXCHANGE, FREE VIRTUAL SCIENCE EDUCATION PLATFORM Market News
European Medicines Agency Validates Bristol Myers Squibb's Application for CAR T Cell Therapy Breyanzi in Relapsed or Refractory Large B-cell Lymphoma After First-Line Therapy Pharmaceutical Investing
